Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

3 factors that lead to missed injuries in multi-trauma CT patients

In patients with multiple traumas, those who were over 30 years old with severe injuries across more than two body parts were more likely to experience a missed injury upon initial CT scan, according to a recent Radiology study.

Thumbnail

1-month post-RT imaging unnecessary for liver cancer patients

“Treatment effect is more reliably determined on imaging at 90 days following SIRT, however imaging at one-month post-SIRT is still frequently performed,” Shamar Young, MD, and colleagues wrote. “This raises the question as to whether or not imaging at one month following SIRT is clinically warranted.”

Thumbnail

Amount, location, size of brain lesions can determine advancement to MS

Identifying the amount, location and size of lesions on MRI can predict the risk of progression from an early stage of multiple sclerosis (MS) to an official diagnosis within a year, according to authors of a new Brain and Behavior study.

Thumbnail

PET imaging method could improve Type 1 diabetes treatment

Yale University researchers have discovered a new PET imaging method that measures beta-cell mass which could improve monitoring, according to research published online in the August issue of the Journal of Nuclear Medicine.  

Thumbnail

PET tracer IDs estrogen receptor variation in breast cancer patients

Dutch researchers utilized a PET tracer to distinguish differences in estrogen receptor (ER) expression in metastatic breast cancer patients, according to a recent Journal of Nuclear Medicine study. Findings may enhance treatment for these patients.

Thumbnail

Cardiac monitoring may protect high-risk breast cancer patients against heart failure

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.

Thumbnail

Molecular imaging tool can map cancer cell division in real-time

Researchers from Columbia University in New York have developed a molecular imaging tool that can track metabolic changes in individual living cells in real time, according to research published July 30 in Nature Communications.

Thumbnail

Mobile imaging system can go where most CT scanners can’t

A new technology hopes to break the geographical barriers keeping patients from diagnostic CT scans. The imaging units are hardly mobile, so one scientist is hoping to put similar tools into people’s hands.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.